The Valley Desk

ArticlePsychopharmacology bulletinPublished

A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Psychopharmacology bulletin
Published
Subject terms
Intranasal; ketamine; Suicide; Mdd; Open Label; Racemic
PubMed ID
38449472
PubMed Central ID
PMC10913863
Added to directory
Source checked

Report a correction or request removal